About Execupharm
Execupharm is a Healthcare company based in King Of Prussia (United States) founded in 2009, and was acquired by Parexel in September 2016. Specialized CRO services are provided to pharma and biotech companies. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Emmes, Syneos Health and Veristat.
Company details
Execupharmas three major offerings include CRO support services, functional and cross-functional resourcing outsourcing and traditional resourcing services to its pharma and biotech clients. Its CRO support services include clinical trial management, monitoring and site management, clinical trial administration, document management, contract and grants management, medical writing, regulatory, and vendor oversight services. The company also provides functional and cross-functional resourcing and outsourcing services, that mainly offer qualified professionals across a specific functional area, along with associated operational services to clients. Under traditional resourcing, it offers its clients with Specific, Qualified Professionals who can end up as permanent employees or as contingent workers. The company was created in 1995 as a global resourcing firm for clients in the pharmaceutical, biotech and medical device industry. It currently has operations in US, Canada, Mexico, Argentina, UK, India, China and Japan. It was acquired by Parexel in September, 2016.
- Headquarters King Of Prussia, United States
- Stage Acquired
- SectorsHealthcare
- Website execupharm.com
- Social LinkedIn X Facebook
- Acquired by Parexel (Sep 2016)
Investors in Execupharm
Execupharm has secured backing from 1 investor. Prominent investors backing the company include Parexel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Full-service clinical research organization services are provided globally by Parexel. | 1983 | parexel.com | Waltham, United States |
Investor details for Execupharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Execupharm
2 dated milestones of Execupharm across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Execupharm is founded.
- Exit Acquired by Parexel.
Competitors of Execupharm
Execupharm has 3 listed competitors in our database. They include Emmes, Syneos Health and Veristat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | 195 | Outsourced contract research organization services are provided to clients. | ||
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| veristat.com | 1994 | Southborough, United States | 7 | Clinical trials and regulatory submissions are supported as a CRO. |
Detailed competitors of Execupharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Execupharm (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Execupharm
Execupharm was founded in 2009.
Execupharm is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Execupharmas three major offerings include CRO support services, functional and cross-functional resourcing outsourcing and traditional resourcing services to its pharma and biotech clients. Its CRO support services include clinical trial management, monitoring and site management, clinical trial administration, document management, contract and grants management, medical writing, regulatory, and vendor oversight services. The company also provides functional and cross-functional resourcing and outsourcing services, that mainly offer qualified professionals across a specific functional area, along with associated operational services to clients. Under traditional resourcing, it offers its clients with Specific, Qualified Professionals who can end up as permanent employees or as contingent workers. The company was created in 1995 as a global resourcing firm for clients in the pharmaceutical, biotech and medical device industry. It currently has operations in US, Canada, Mexico, Argentina, UK, India, China and Japan. It was acquired by Parexel in September, 2016.
Execupharm's top competitors include Emmes, Syneos Health and Veristat.
Execupharm has 1 investor. Key investors include Parexel.
Yes. Execupharm was acquired by Parexel in September 2016.